| Financial Year |
March 31 2023 |
| Monetary Funds |
21,170,456,000.00 |
| Held-for-trading Financial Assets |
13,921,758,000.00 |
| Notes Receivable |
74,673,000.00 |
| Accounts Receivable |
3,551,902,000.00 |
| Advances to Suppliers |
12,316,531,000.00 |
| Other Receivables |
2,361,764,000.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
8,917,138,000.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
145,468,000.00 |
| Other Current Assets |
2,410,553,000.00 |
| Total Current Assets |
64,871,249,000.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,501,969,000.00 |
| Long-term Equity Investment |
13,840,446,000.00 |
| Investment Properties |
8,030,692,000.00 |
| Fixed Assetes |
10,162,129,000.00 |
| Under-construction Projects |
3,796,166,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
8,033,198,000.00 |
| R&D expenses |
2,734,000.00 |
| Goodwill |
2,606,717,000.00 |
| Long-Term Deferred and Prepaid Expenses |
321,741,000.00 |
| Deferred Income Tax Assets |
12,369,171,000.00 |
| Other Non-Current Assets |
362,709,000.00 |
| Sub-Total of Non-Current Assets |
79,841,749,000.00 |
| Total Assets |
144,712,998,000.00 |
| Short-Term Loans |
32,108,755,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
11,923,857,000.00 |
| Accounts Payable |
18,301,604,000.00 |
| Accounts Received In Advance |
372,238,000.00 |
| Employee Compensation Payable |
1,227,473,000.00 |
| Taxes Payable |
1,466,709,000.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
20,820,150,000.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,181,094,000.00 |
| Other Current Liabilities |
739,721,000.00 |
| Sub-Total of Current Liabilities |
109,545,258,000.00 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
917,654,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,573,839,000.00 |
| Other Non-Current Liabilities |
739,026,000.00 |
| Sub-Total of Non-Current Liabilities |
20,217,635,000.00 |
| Total Liabilities |
129,762,893,000.00 |
| Paid-In Capital(Or Share Stock) |
9,310,040,000.00 |
| Capital Surplus |
32,466,404,000.00 |
| Surplus Reserve |
1,809,757,000.00 |
| LESS:Treasury Stock |
2,009,568,000.00 |
| Undistributed Profits |
-23,900,314,000.00 |
| Minority Stockholder's Interest |
-1,115,335,000.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
16,065,440,000.00 |
| Owner's Equity（Stockholder's Equity） |
14,950,105,000.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
144,712,998,000.00 |
